Clinical Trial Update: To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing safety, reactogenicity, and immunogenicity of two doses of GSK's oral rotavirus vaccine in pre-term infants; results were completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis Rotavirus
• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2009-05-04